Vardenafil Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Vardenafil Hydrochloride
US Patents

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Vardenafil Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 6 USDMF, 5 CEP/COS, 2 JDMF, 8 EU WC, 2 KDMF, 13 NDC API, 20 Listed Suppliers, $ API Reference Price

26 API Suppliers
6 USDMF
5 CEP/COS
2 JDMF
8 EU WC
2 KDMF
13 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

102 FDF Dossiers, 32 FDA Orange Book, 39 Europe, 6 Canada, 5 South Africa, 20 Listed Dossiers

102 FDF Dossiers
32 FDA Orange Book
39 Europe
6 Canada
5 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 3 DKSH, 2 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 24 Controlled & Modified Release, 22 Direct Compression, 17 Thickeners and Stabilizers, 16 Taste Masking, 14 Chewable & Orodispersible Aids, 14 Film Formers & Plasticizers, 12 Co-Processed Excipients, 11 Granulation, 11 Lubricants & Glidants, 8 Parenteral, 7 Topical, 6 Disintegrants & Superdisintegrants, 5 Solubilizers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Rheology Modifiers, 1 Soft Gelatin

45 Coating Systems & Additives
42 Fillers, Diluents & Binders
24 Controlled & Modified Release
22 Direct Compression
17 Thickeners and Stabilizers
16 Taste Masking
14 Chewable & Orodispersible Aids
14 Film Formers & Plasticizers
12 Co-Processed Excipients
11 Granulation
11 Lubricants & Glidants
8 Parenteral
7 Topical
6 Disintegrants & Superdisintegrants
5 Solubilizers
5 Empty Capsules
5 API Stability Enhancers
4 Coloring Agents
4 Emulsifying Agents
4 Vegetarian Capsules
2 Rheology Modifiers
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 26 Finished Drug Prices, 2 Annual Reports

1 US Medicaid Prescriptions
26 Finished Drug Prices
2 Annual Reports

MARKET PLACE

12 APIs

12 APIs

PATENTS & EXCLUSIVITIES

5 US Patents, 5 Health Canada Patents

5 US Patents
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 11 Others

2 USP
11 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,164 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 5BAYER HLTHCARE

filter Patent Number Reset all filters

5 All

01 48273876

02 18613950

filter API Patent Reset all filters

5 All

01 5Blank

filter FDF Patent Reset all filters

5 All

01 1Y

02 4Blank

filter Expiration Date Reset all filters

5 All

01 42027-07-23

02 12028-12-23

Product Main Page

01

BAYER HLTHCARE

VARDENAFIL HYDROCHLORIDE

Fi Europe 2024

Not Confirmed

BAYER HLTHCARE

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

VARDENAFIL HYDROCHLORIDE

US Patent Number : 8273876

Drug Substance Claim :

Drug Product Claim :

Application Number : 21400

Patent Use Code : U-1288

Delist Requested :

Patent Use Description : TREATEMENT OF ERECTIIL...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BAYER HLTHCARE

VARDENAFIL HYDROCHLORIDE

Fi Europe 2024

Not Confirmed

BAYER HLTHCARE

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

VARDENAFIL HYDROCHLORIDE

US Patent Number : 8273876

Drug Substance Claim :

Drug Product Claim :

Application Number : 21400

Patent Use Code : U-1288

Delist Requested :

Patent Use Description : TREATEMENT OF ERECTIIL...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BAYER HLTHCARE

VARDENAFIL HYDROCHLORIDE

Fi Europe 2024

Not Confirmed

BAYER HLTHCARE

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

VARDENAFIL HYDROCHLORIDE

US Patent Number : 8273876

Drug Substance Claim :

Drug Product Claim :

Application Number : 21400

Patent Use Code : U-1288

Delist Requested :

Patent Use Description : TREATEMENT OF ERECTIIL...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BAYER HLTHCARE

VARDENAFIL HYDROCHLORIDE

Fi Europe 2024

Not Confirmed

BAYER HLTHCARE

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

VARDENAFIL HYDROCHLORIDE

US Patent Number : 8273876

Drug Substance Claim :

Drug Product Claim :

Application Number : 21400

Patent Use Code : U-1288

Delist Requested :

Patent Use Description : TREATEMENT OF ERECTIIL...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BAYER HLTHCARE

VARDENAFIL HYDROCHLORIDE

Fi Europe 2024

Not Confirmed

BAYER HLTHCARE

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-12-23

VARDENAFIL HYDROCHLORIDE

US Patent Number : 8613950

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 200179

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-12-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?